nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—scrotum—muscle cancer	0.104	0.513	CbGeAlD
Cyproterone acetate—AR—smooth muscle tissue—muscle cancer	0.0079	0.0392	CbGeAlD
Cyproterone acetate—AR—renal system—muscle cancer	0.00761	0.0377	CbGeAlD
Cyproterone acetate—NR3C1—embryo—muscle cancer	0.00728	0.0361	CbGeAlD
Cyproterone acetate—AR—cardiac atrium—muscle cancer	0.00681	0.0338	CbGeAlD
Cyproterone acetate—AR—tendon—muscle cancer	0.00594	0.0294	CbGeAlD
Cyproterone acetate—CYP19A1—head—muscle cancer	0.00575	0.0285	CbGeAlD
Cyproterone acetate—NR3C1—smooth muscle tissue—muscle cancer	0.00572	0.0284	CbGeAlD
Cyproterone acetate—CYP19A1—testis—muscle cancer	0.00556	0.0275	CbGeAlD
Cyproterone acetate—AR—vagina—muscle cancer	0.00551	0.0273	CbGeAlD
Cyproterone acetate—NR3C1—renal system—muscle cancer	0.00551	0.0273	CbGeAlD
Cyproterone acetate—AR—head—muscle cancer	0.00509	0.0252	CbGeAlD
Cyproterone acetate—NR3C1—cardiac atrium—muscle cancer	0.00494	0.0245	CbGeAlD
Cyproterone acetate—AR—testis—muscle cancer	0.00492	0.0244	CbGeAlD
Cyproterone acetate—NR3C1—tendon—muscle cancer	0.0043	0.0213	CbGeAlD
Cyproterone acetate—NR3C1—bone marrow—muscle cancer	0.00417	0.0206	CbGeAlD
Cyproterone acetate—NR3C1—vagina—muscle cancer	0.00399	0.0198	CbGeAlD
Cyproterone acetate—NR3C1—head—muscle cancer	0.00369	0.0183	CbGeAlD
Cyproterone acetate—NR3C1—testis—muscle cancer	0.00356	0.0176	CbGeAlD
Cyproterone acetate—Renal failure—Etoposide—muscle cancer	0.00246	0.00318	CcSEcCtD
Cyproterone acetate—Myocardial infarction—Etoposide—muscle cancer	0.00246	0.00317	CcSEcCtD
Cyproterone acetate—Alopecia—Vincristine—muscle cancer	0.00245	0.00316	CcSEcCtD
Cyproterone acetate—Coma—Methotrexate—muscle cancer	0.00245	0.00316	CcSEcCtD
Cyproterone acetate—Jaundice—Etoposide—muscle cancer	0.00244	0.00315	CcSEcCtD
Cyproterone acetate—Creatinine increased—Doxorubicin—muscle cancer	0.00244	0.00315	CcSEcCtD
Cyproterone acetate—Malaise—Dactinomycin—muscle cancer	0.00244	0.00315	CcSEcCtD
Cyproterone acetate—Mental disorder—Vincristine—muscle cancer	0.00243	0.00314	CcSEcCtD
Cyproterone acetate—Neoplasm—Methotrexate—muscle cancer	0.00243	0.00313	CcSEcCtD
Cyproterone acetate—Leukopenia—Dactinomycin—muscle cancer	0.00242	0.00312	CcSEcCtD
Cyproterone acetate—Gynaecomastia—Methotrexate—muscle cancer	0.0024	0.0031	CcSEcCtD
Cyproterone acetate—Gait disturbance—Doxorubicin—muscle cancer	0.00238	0.00307	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Etoposide—muscle cancer	0.00237	0.00306	CcSEcCtD
Cyproterone acetate—Pulmonary embolism—Doxorubicin—muscle cancer	0.00232	0.003	CcSEcCtD
Cyproterone acetate—Injection site reaction—Doxorubicin—muscle cancer	0.00231	0.00298	CcSEcCtD
Cyproterone acetate—Discomfort—Dactinomycin—muscle cancer	0.00228	0.00293	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Methotrexate—muscle cancer	0.00225	0.0029	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Methotrexate—muscle cancer	0.00224	0.00289	CcSEcCtD
Cyproterone acetate—Anaemia—Vincristine—muscle cancer	0.00223	0.00288	CcSEcCtD
Cyproterone acetate—Agitation—Vincristine—muscle cancer	0.00222	0.00286	CcSEcCtD
Cyproterone acetate—Oedema—Dactinomycin—muscle cancer	0.00221	0.00285	CcSEcCtD
Cyproterone acetate—Fluid retention—Doxorubicin—muscle cancer	0.00221	0.00284	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYF5—muscle cancer	0.00219	0.0963	CbGpPWpGaD
Cyproterone acetate—Hepatic failure—Methotrexate—muscle cancer	0.00217	0.00279	CcSEcCtD
Cyproterone acetate—Leukopenia—Vincristine—muscle cancer	0.00216	0.00279	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Dactinomycin—muscle cancer	0.00216	0.00279	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Etoposide—muscle cancer	0.00213	0.00274	CcSEcCtD
Cyproterone acetate—Coma—Doxorubicin—muscle cancer	0.00212	0.00274	CcSEcCtD
Cyproterone acetate—Rash maculo-papular—Doxorubicin—muscle cancer	0.00211	0.00272	CcSEcCtD
Cyproterone acetate—Anorexia—Dactinomycin—muscle cancer	0.0021	0.00271	CcSEcCtD
Cyproterone acetate—Eye disorder—Etoposide—muscle cancer	0.0021	0.00271	CcSEcCtD
Cyproterone acetate—Neoplasm—Doxorubicin—muscle cancer	0.0021	0.00271	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00206	0.00266	CcSEcCtD
Cyproterone acetate—Angiopathy—Etoposide—muscle cancer	0.00204	0.00263	CcSEcCtD
Cyproterone acetate—Immune system disorder—Etoposide—muscle cancer	0.00203	0.00262	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Etoposide—muscle cancer	0.00203	0.00261	CcSEcCtD
Cyproterone acetate—Abnormal vision—Doxorubicin—muscle cancer	0.00203	0.00261	CcSEcCtD
Cyproterone acetate—Chills—Etoposide—muscle cancer	0.00202	0.0026	CcSEcCtD
Cyproterone acetate—Alopecia—Etoposide—muscle cancer	0.00199	0.00256	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Methotrexate—muscle cancer	0.00199	0.00256	CcSEcCtD
Cyproterone acetate—Oedema—Vincristine—muscle cancer	0.00197	0.00254	CcSEcCtD
Cyproterone acetate—Phlebitis—Doxorubicin—muscle cancer	0.00196	0.00252	CcSEcCtD
Cyproterone acetate—Thrombophlebitis—Doxorubicin—muscle cancer	0.00195	0.00251	CcSEcCtD
Cyproterone acetate—Diabetes mellitus—Doxorubicin—muscle cancer	0.00194	0.0025	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Vincristine—muscle cancer	0.00193	0.00249	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Vincristine—muscle cancer	0.00193	0.00249	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dactinomycin—muscle cancer	0.00192	0.00247	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Vincristine—muscle cancer	0.00191	0.00246	CcSEcCtD
Cyproterone acetate—Fatigue—Dactinomycin—muscle cancer	0.0019	0.00245	CcSEcCtD
Cyproterone acetate—Anorexia—Vincristine—muscle cancer	0.00188	0.00242	CcSEcCtD
Cyproterone acetate—Eczema—Doxorubicin—muscle cancer	0.00188	0.00242	CcSEcCtD
Cyproterone acetate—Hepatic failure—Doxorubicin—muscle cancer	0.00188	0.00242	CcSEcCtD
Cyproterone acetate—Mood swings—Methotrexate—muscle cancer	0.00184	0.00238	CcSEcCtD
Cyproterone acetate—Hypotension—Vincristine—muscle cancer	0.00184	0.00238	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dactinomycin—muscle cancer	0.00182	0.00235	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Etoposide—muscle cancer	0.00182	0.00234	CcSEcCtD
Cyproterone acetate—Anaemia—Etoposide—muscle cancer	0.00181	0.00233	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00181	0.00233	CcSEcCtD
Cyproterone acetate—Hot flush—Doxorubicin—muscle cancer	0.0018	0.00232	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Methotrexate—muscle cancer	0.0018	0.00232	CcSEcCtD
Cyproterone acetate—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00179	0.0023	CcSEcCtD
Cyproterone acetate—Menopausal symptoms—Doxorubicin—muscle cancer	0.00179	0.0023	CcSEcCtD
Cyproterone acetate—Malaise—Etoposide—muscle cancer	0.00177	0.00228	CcSEcCtD
Cyproterone acetate—Breast disorder—Methotrexate—muscle cancer	0.00176	0.00227	CcSEcCtD
Cyproterone acetate—Leukopenia—Etoposide—muscle cancer	0.00175	0.00226	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dactinomycin—muscle cancer	0.00175	0.00225	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dactinomycin—muscle cancer	0.00175	0.00225	CcSEcCtD
Cyproterone acetate—Cardiac failure—Doxorubicin—muscle cancer	0.00173	0.00223	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Etoposide—muscle cancer	0.00172	0.00222	CcSEcCtD
Cyproterone acetate—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00172	0.00222	CcSEcCtD
Cyproterone acetate—Decreased appetite—Vincristine—muscle cancer	0.00171	0.00221	CcSEcCtD
Cyproterone acetate—Cough—Etoposide—muscle cancer	0.00171	0.0022	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Vincristine—muscle cancer	0.0017	0.0022	CcSEcCtD
Cyproterone acetate—Fatigue—Vincristine—muscle cancer	0.0017	0.00219	CcSEcCtD
Cyproterone acetate—Constipation—Vincristine—muscle cancer	0.00169	0.00218	CcSEcCtD
Cyproterone acetate—Asthma—Methotrexate—muscle cancer	0.00168	0.00217	CcSEcCtD
Cyproterone acetate—Affect lability—Doxorubicin—muscle cancer	0.00166	0.00214	CcSEcCtD
Cyproterone acetate—Migraine—Doxorubicin—muscle cancer	0.00166	0.00214	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00166	0.00213	CcSEcCtD
Cyproterone acetate—Pancreatitis—Methotrexate—muscle cancer	0.00165	0.00213	CcSEcCtD
Cyproterone acetate—Discomfort—Etoposide—muscle cancer	0.00165	0.00212	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Dactinomycin—muscle cancer	0.00163	0.0021	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Vincristine—muscle cancer	0.00161	0.00208	CcSEcCtD
Cyproterone acetate—Mood swings—Doxorubicin—muscle cancer	0.0016	0.00206	CcSEcCtD
Cyproterone acetate—Asthenia—Dactinomycin—muscle cancer	0.00158	0.00204	CcSEcCtD
Cyproterone acetate—Blood creatinine increased—Doxorubicin—muscle cancer	0.00158	0.00204	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	0.00157	0.0689	CbGpPWpGaD
Cyproterone acetate—Thrombocytopenia—Etoposide—muscle cancer	0.00156	0.00202	CcSEcCtD
Cyproterone acetate—Tachycardia—Etoposide—muscle cancer	0.00156	0.00201	CcSEcCtD
Cyproterone acetate—Abdominal pain—Vincristine—muscle cancer	0.00156	0.00201	CcSEcCtD
Cyproterone acetate—Body temperature increased—Vincristine—muscle cancer	0.00156	0.00201	CcSEcCtD
Cyproterone acetate—Liver function test abnormal—Doxorubicin—muscle cancer	0.00156	0.00201	CcSEcCtD
Cyproterone acetate—Skin disorder—Etoposide—muscle cancer	0.00155	0.002	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—muscle cancer	0.00155	0.002	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Etoposide—muscle cancer	0.00154	0.00199	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—muscle cancer	0.00154	0.00198	CcSEcCtD
Cyproterone acetate—Breast disorder—Doxorubicin—muscle cancer	0.00152	0.00197	CcSEcCtD
Cyproterone acetate—Anorexia—Etoposide—muscle cancer	0.00152	0.00196	CcSEcCtD
Cyproterone acetate—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.00152	0.00196	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dactinomycin—muscle cancer	0.00151	0.00195	CcSEcCtD
Cyproterone acetate—Hypotension—Etoposide—muscle cancer	0.00149	0.00193	CcSEcCtD
Cyproterone acetate—Muscular weakness—Doxorubicin—muscle cancer	0.00149	0.00192	CcSEcCtD
Cyproterone acetate—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00149	0.00192	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—muscle cancer	0.00148	0.0019	CcSEcCtD
Cyproterone acetate—Asthma—Doxorubicin—muscle cancer	0.00146	0.00188	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Vincristine—muscle cancer	0.00145	0.00187	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—muscle cancer	0.00144	0.00186	CcSEcCtD
Cyproterone acetate—Haematuria—Methotrexate—muscle cancer	0.00143	0.00185	CcSEcCtD
Cyproterone acetate—Pancreatitis—Doxorubicin—muscle cancer	0.00143	0.00184	CcSEcCtD
Cyproterone acetate—Dyspnoea—Etoposide—muscle cancer	0.00142	0.00184	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—muscle cancer	0.00142	0.00183	CcSEcCtD
Cyproterone acetate—Asthenia—Vincristine—muscle cancer	0.00142	0.00183	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYOG—muscle cancer	0.00141	0.062	CbGpPWpGaD
Cyproterone acetate—Vomiting—Dactinomycin—muscle cancer	0.0014	0.00181	CcSEcCtD
Cyproterone acetate—Rash—Dactinomycin—muscle cancer	0.00139	0.0018	CcSEcCtD
Cyproterone acetate—Decreased appetite—Etoposide—muscle cancer	0.00139	0.00179	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Etoposide—muscle cancer	0.00138	0.00178	CcSEcCtD
Cyproterone acetate—Fatigue—Etoposide—muscle cancer	0.00138	0.00178	CcSEcCtD
Cyproterone acetate—Constipation—Etoposide—muscle cancer	0.00137	0.00176	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—muscle cancer	0.00135	0.00175	CcSEcCtD
Cyproterone acetate—Diarrhoea—Vincristine—muscle cancer	0.00135	0.00174	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—muscle cancer	0.00135	0.00174	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—muscle cancer	0.00135	0.00174	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—muscle cancer	0.00135	0.00174	CcSEcCtD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—MYOD1—muscle cancer	0.00134	0.0587	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00133	0.00172	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—muscle cancer	0.00133	0.00171	CcSEcCtD
Cyproterone acetate—Weight decreased—Doxorubicin—muscle cancer	0.00132	0.0017	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Etoposide—muscle cancer	0.00132	0.0017	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—muscle cancer	0.00131	0.0017	CcSEcCtD
Cyproterone acetate—Nausea—Dactinomycin—muscle cancer	0.00131	0.00169	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Etoposide—muscle cancer	0.00131	0.00169	CcSEcCtD
Cyproterone acetate—Dizziness—Vincristine—muscle cancer	0.0013	0.00168	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—muscle cancer	0.0013	0.00167	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—muscle cancer	0.00128	0.00165	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—muscle cancer	0.00127	0.00164	CcSEcCtD
Cyproterone acetate—Urticaria—Etoposide—muscle cancer	0.00127	0.00164	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—muscle cancer	0.00127	0.00163	CcSEcCtD
Cyproterone acetate—Body temperature increased—Etoposide—muscle cancer	0.00126	0.00163	CcSEcCtD
Cyproterone acetate—Abdominal pain—Etoposide—muscle cancer	0.00126	0.00163	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—muscle cancer	0.00126	0.00162	CcSEcCtD
Cyproterone acetate—Vomiting—Vincristine—muscle cancer	0.00125	0.00162	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—muscle cancer	0.00125	0.00161	CcSEcCtD
Cyproterone acetate—Rash—Vincristine—muscle cancer	0.00124	0.0016	CcSEcCtD
Cyproterone acetate—Dermatitis—Vincristine—muscle cancer	0.00124	0.0016	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—muscle cancer	0.00124	0.0016	CcSEcCtD
Cyproterone acetate—Headache—Vincristine—muscle cancer	0.00124	0.00159	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00123	0.00158	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—muscle cancer	0.00122	0.00158	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—muscle cancer	0.00122	0.00157	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—muscle cancer	0.00121	0.00157	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—muscle cancer	0.00121	0.00156	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—muscle cancer	0.00119	0.00154	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFE3—muscle cancer	0.00119	0.0523	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Methotrexate—muscle cancer	0.00118	0.00152	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—muscle cancer	0.00118	0.00152	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—muscle cancer	0.00117	0.00151	CcSEcCtD
Cyproterone acetate—Haemoglobin—Doxorubicin—muscle cancer	0.00117	0.00151	CcSEcCtD
Cyproterone acetate—Nausea—Vincristine—muscle cancer	0.00117	0.00151	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—muscle cancer	0.00117	0.0015	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—muscle cancer	0.00117	0.0015	CcSEcCtD
Cyproterone acetate—Asthenia—Etoposide—muscle cancer	0.00115	0.00148	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—muscle cancer	0.00115	0.00148	CcSEcCtD
Cyproterone acetate—Pruritus—Etoposide—muscle cancer	0.00113	0.00146	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—muscle cancer	0.00112	0.00145	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—muscle cancer	0.0011	0.00142	CcSEcCtD
Cyproterone acetate—Diarrhoea—Etoposide—muscle cancer	0.00109	0.00141	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—muscle cancer	0.00109	0.00141	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—muscle cancer	0.00109	0.0014	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—muscle cancer	0.00108	0.0014	CcSEcCtD
Cyproterone acetate—Angiopathy—Doxorubicin—muscle cancer	0.00106	0.00136	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—muscle cancer	0.00106	0.00136	CcSEcCtD
Cyproterone acetate—Dizziness—Etoposide—muscle cancer	0.00106	0.00136	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—muscle cancer	0.00105	0.00136	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—muscle cancer	0.00105	0.00136	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—muscle cancer	0.00105	0.00135	CcSEcCtD
Cyproterone acetate—Chills—Doxorubicin—muscle cancer	0.00105	0.00135	CcSEcCtD
Cyproterone acetate—Alopecia—Doxorubicin—muscle cancer	0.00103	0.00133	CcSEcCtD
Cyproterone acetate—Cough—Methotrexate—muscle cancer	0.00102	0.00132	CcSEcCtD
Cyproterone acetate—Mental disorder—Doxorubicin—muscle cancer	0.00102	0.00132	CcSEcCtD
Cyproterone acetate—Vomiting—Etoposide—muscle cancer	0.00102	0.00131	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—muscle cancer	0.00102	0.00131	CcSEcCtD
Cyproterone acetate—Rash—Etoposide—muscle cancer	0.00101	0.0013	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—muscle cancer	0.00101	0.0013	CcSEcCtD
Cyproterone acetate—Headache—Etoposide—muscle cancer	0.001	0.00129	CcSEcCtD
Cyproterone acetate—Tension—Doxorubicin—muscle cancer	0.000996	0.00129	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000991	0.00128	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—muscle cancer	0.000986	0.00127	CcSEcCtD
Cyproterone acetate—Nausea—Etoposide—muscle cancer	0.000949	0.00122	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—muscle cancer	0.000942	0.00122	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—muscle cancer	0.000939	0.00121	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—muscle cancer	0.000939	0.00121	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—muscle cancer	0.000937	0.00121	CcSEcCtD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—muscle cancer	0.000933	0.041	CbGpPWpGaD
Cyproterone acetate—Agitation—Doxorubicin—muscle cancer	0.000933	0.0012	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—muscle cancer	0.00093	0.0012	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—muscle cancer	0.000925	0.00119	CcSEcCtD
Cyproterone acetate—Malaise—Doxorubicin—muscle cancer	0.000916	0.00118	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—muscle cancer	0.000912	0.00118	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—muscle cancer	0.000911	0.00117	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—muscle cancer	0.000909	0.00117	CcSEcCtD
Cyproterone acetate—CYP19A1—FSH signaling pathway—FOXO1—muscle cancer	0.000899	0.0395	CbGpPWpGaD
Cyproterone acetate—Hypotension—Methotrexate—muscle cancer	0.000894	0.00115	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Doxorubicin—muscle cancer	0.000892	0.00115	CcSEcCtD
Cyproterone acetate—Cough—Doxorubicin—muscle cancer	0.000886	0.00114	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	0.000864	0.0379	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000859	0.00111	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—muscle cancer	0.000854	0.0011	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—muscle cancer	0.000853	0.0011	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—muscle cancer	0.000842	0.00109	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—muscle cancer	0.000832	0.00107	CcSEcCtD
Cyproterone acetate—Oedema—Doxorubicin—muscle cancer	0.000829	0.00107	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000826	0.00107	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—muscle cancer	0.000825	0.00106	CcSEcCtD
Cyproterone acetate—Shock—Doxorubicin—muscle cancer	0.000815	0.00105	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Doxorubicin—muscle cancer	0.000813	0.00105	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—muscle cancer	0.000811	0.00105	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—muscle cancer	0.000809	0.00104	CcSEcCtD
Cyproterone acetate—Skin disorder—Doxorubicin—muscle cancer	0.000805	0.00104	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—muscle cancer	0.000801	0.00103	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MED12—muscle cancer	0.000798	0.0351	CbGpPWpGaD
Cyproterone acetate—Anorexia—Doxorubicin—muscle cancer	0.00079	0.00102	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methotrexate—muscle cancer	0.000789	0.00102	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000783	0.00101	CcSEcCtD
Cyproterone acetate—Hypotension—Doxorubicin—muscle cancer	0.000774	0.000999	CcSEcCtD
Cyproterone acetate—Urticaria—Methotrexate—muscle cancer	0.00076	0.000981	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—muscle cancer	0.000757	0.000976	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—muscle cancer	0.000757	0.000976	CcSEcCtD
Cyproterone acetate—Dyspnoea—Doxorubicin—muscle cancer	0.000739	0.000953	CcSEcCtD
Cyproterone acetate—Dyspepsia—Doxorubicin—muscle cancer	0.000729	0.000941	CcSEcCtD
Cyproterone acetate—Decreased appetite—Doxorubicin—muscle cancer	0.00072	0.000929	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000715	0.000923	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—muscle cancer	0.000714	0.000921	CcSEcCtD
Cyproterone acetate—Constipation—Doxorubicin—muscle cancer	0.000709	0.000914	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methotrexate—muscle cancer	0.000705	0.000909	CcSEcCtD
Cyproterone acetate—Asthenia—Methotrexate—muscle cancer	0.000687	0.000886	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Doxorubicin—muscle cancer	0.000683	0.000881	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000678	0.000874	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—muscle cancer	0.000677	0.000873	CcSEcCtD
Cyproterone acetate—Urticaria—Doxorubicin—muscle cancer	0.000658	0.000849	CcSEcCtD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—muscle cancer	0.000655	0.0288	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Doxorubicin—muscle cancer	0.000655	0.000845	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—muscle cancer	0.000655	0.000845	CcSEcCtD
Cyproterone acetate—Diarrhoea—Methotrexate—muscle cancer	0.000655	0.000845	CcSEcCtD
Cyproterone acetate—Dizziness—Methotrexate—muscle cancer	0.000633	0.000816	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000627	0.0276	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Doxorubicin—muscle cancer	0.000611	0.000787	CcSEcCtD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—FOXO1—muscle cancer	0.000609	0.0267	CbGpPWpGaD
Cyproterone acetate—Vomiting—Methotrexate—muscle cancer	0.000609	0.000785	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—muscle cancer	0.000603	0.000778	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—muscle cancer	0.000603	0.000778	CcSEcCtD
Cyproterone acetate—Headache—Methotrexate—muscle cancer	0.0006	0.000773	CcSEcCtD
Cyproterone acetate—Asthenia—Doxorubicin—muscle cancer	0.000595	0.000767	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	0.000587	0.0258	CbGpPWpGaD
Cyproterone acetate—Pruritus—Doxorubicin—muscle cancer	0.000586	0.000756	CcSEcCtD
Cyproterone acetate—Nausea—Methotrexate—muscle cancer	0.000568	0.000733	CcSEcCtD
Cyproterone acetate—Diarrhoea—Doxorubicin—muscle cancer	0.000567	0.000731	CcSEcCtD
Cyproterone acetate—Dizziness—Doxorubicin—muscle cancer	0.000548	0.000707	CcSEcCtD
Cyproterone acetate—Vomiting—Doxorubicin—muscle cancer	0.000527	0.00068	CcSEcCtD
Cyproterone acetate—Rash—Doxorubicin—muscle cancer	0.000523	0.000674	CcSEcCtD
Cyproterone acetate—Dermatitis—Doxorubicin—muscle cancer	0.000522	0.000673	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—muscle cancer	0.000519	0.00067	CcSEcCtD
Cyproterone acetate—Nausea—Doxorubicin—muscle cancer	0.000492	0.000635	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TP73—muscle cancer	0.000476	0.0209	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—FOXO1—muscle cancer	0.000462	0.0203	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO4—muscle cancer	0.000446	0.0196	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	0.000434	0.0191	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000404	0.0178	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—FOXO1—muscle cancer	0.000402	0.0177	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of Androgen receptor activity—MDM2—muscle cancer	0.000365	0.0161	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Tryptophan metabolism—MDM2—muscle cancer	0.000352	0.0155	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—HMGA1—muscle cancer	0.00034	0.0149	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—CDKN2A—muscle cancer	0.000337	0.0148	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—muscle cancer	0.000329	0.0145	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000296	0.013	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of Androgen receptor activity—MDM2—muscle cancer	0.000277	0.0122	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.000271	0.0119	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.000264	0.0116	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—MDM2—muscle cancer	0.000241	0.0106	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CDKN2A—muscle cancer	0.000229	0.01	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.000227	0.00996	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—FOXO1—muscle cancer	0.000225	0.0099	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MED12—muscle cancer	0.000198	0.00868	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.000196	0.00859	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.000158	0.00695	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MED12—muscle cancer	0.00015	0.00658	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000143	0.00628	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—muscle cancer	0.000136	0.00598	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000131	0.00576	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—muscle cancer	0.000127	0.00559	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000126	0.00555	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.00012	0.00527	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—muscle cancer	0.000117	0.00514	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—FH—muscle cancer	0.000113	0.00495	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000112	0.00493	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	0.000103	0.00454	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	9.95e-05	0.00437	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MED12—muscle cancer	9.51e-05	0.00418	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—muscle cancer	9.07e-05	0.00399	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—muscle cancer	8.88e-05	0.0039	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—muscle cancer	7.81e-05	0.00343	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	7.52e-05	0.0033	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MED12—muscle cancer	7.22e-05	0.00317	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MED12—muscle cancer	6.37e-05	0.0028	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ENO2—muscle cancer	5.8e-05	0.00255	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.54e-05	0.00199	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—muscle cancer	2.02e-05	0.000888	CbGpPWpGaD
